Semaglutide In the SURMOUNT1 trial, adults with obesity but no diabetes lost about 16%, 21%, and 22.5% of their starting weight on tirzepatide 5 mg, 10 mg, and 15 mg once weekly, with average losses at the top dose around 52 pounds. In the STEP 1 trial semaglutide obesity trials, onceweekly semaglutide 2.4 mg produced roughly 15% average weight loss at 68 weeks, far outperforming placebo and older agents. A 2025 metaanalysis pooling randomized trials and realworld cohorts found tirzepatide produced about 4 percentage points more weight loss than semaglutide overall , with a clear doseresponse when tirzepatide doses exceeded 10 mg. Recent headtohead and cohort work in adults with overweight or obesity confirms this pattern: tirzepatide is consistently superior for absolute weight and waistcircumference reduction at roughly 72 weeks. What do those percentages mean in real life
[1] [2] The mechanism of action of Ozempic centres on mimicking the naturally occurring hormone GLP-1, which is released by the intestine in response to food intake
Abstract Reactive oxygen species (ROS) are widely known as highly reactive signalling and transcription factors
Some of these are minor, while others may require more attention
Expert advice can help avoid side effects and make it easier to maintain your weight over time
The most common eye flickering causes are: Fatigue and poor sleep the single most consistent trigger
